Doron Betel

34PUBLICATIONS
190CO-AUTHORS
Engineering electromagneticsMolecular targetsMicrofluidics and nanofluidicsTissue engineeringHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Sep 17, 2026
Hypoxia-activated scleraxis a mediates epicardial progenitor differentiation into a unique cardiac perivascular cell type.

|Aug 26, 2026
Neoadjuvant Botensilimab/Balstilimab for localized mismatch repair proficient and deficient colon cancer: Results of the NEST phase 2 clinical trial.

|Aug 05, 2026
Tumoral extracellular vesicles and particles reprogram interstitial macrophages in the lung to promote vascular permeability and metastasis.

|May 13, 2026
Hypoxia-activated scleraxis a mediates epicardial progenitor differentiation into a unique cardiac perivascular cell type.

|Feb 27, 2026
TOX drives CD4+ TH1 effector function, antitumor immunity and autoimmune pathology.

Brianna Naizir, Andrew C Scott, Paul Zumbo

|Feb 24, 2026
Dynamic antigen expression and cytotoxic T cell resistance in HIV reservoir clones.

Isabella A T M Ferreira, Alberto Herrera, Tan Thinh Huynh

Pageof 6

Frequent Collaborators

8 joint publications

Friederike Dündar

5 joint publications

Jingli Cao

5 joint publications

Paul Zumbo

3 joint publications

Jonathan Rub